Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corbus Pharmaceuticals Holdings (CRBP) Long-Term Investments (2022)

Corbus Pharmaceuticals Holdings has reported Long-Term Investments over the past 1 years, most recently at $16.8 million for Q4 2022.

  • For Q4 2022, Long-Term Investments changed N/A year-over-year to $16.8 million; the TTM value through Dec 2022 reached $16.8 million, changed N/A, while the annual FY2022 figure was $16.8 million, N/A changed from the prior year.
  • Long-Term Investments for Q4 2022 was $16.8 million at Corbus Pharmaceuticals Holdings.
  • Over five years, Long-Term Investments peaked at $16.8 million in Q4 2022 and troughed at $16.8 million in Q4 2022.